Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases
Disease Category: Allergy (Pediatric)
Trial Information
72 week growth study in pre-pubescent children to assess growth rate while taking study drug vs. placebo.
Orally Inhaled Corticosteroids: Evaluation of effects on growth in children.
Patient Inclusion Criteria:
- Females, 5 years old to 7.5 years old, Males 5 years old to 8.5 years old.
- History of Perennial allergic rhinitis (year round allergies) with positive skin test to appropriate pollens.
- Height and weight with in normal parameters.
*Other inclusion criteria will apply.
Patient Exclusion Criteria:
- History of abnormal growth, or conditions that affect growth.
- Severe Asthma.,/li>
- History of nasal or sinus surgery.
*Other exclusion criteria will apply.
Nancy Canada, Study Coordinator
Allergy Asthma Research Institute
333 Londonderry Drive, Suite #110
Waco, TX 76712
Phone: (254) 751-1144 option 11
Fax: (254) 751-9922
EMail: ncanada@aactx.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
